Ecofibre and Ananda Professional Open Registration for CBD360
19 juil. 2022 16h00 HE
|
Ecofibre Ltd.
GEORGETOWN, Ky., July 19, 2022 (GLOBE NEWSWIRE) -- Ananda Professional has provided training and education to over 5,000 healthcare professionals and pharmacists through various events and seminars...
Purple Biotech Announces Executive Leadership Changes
14 juil. 2022 07h30 HE
|
Purple Biotech Ltd.
Gil Efron appointed as Chief Executive Officer Isaac Israel to transition to advisor role, continue as Board member REHOVOT, Israel, July 14, 2022 (GLOBE NEWSWIRE) -- Purple Biotech Ltd....
SciSparc Ltd. Announces Initial Positive Results for the Cocaine Addiction Treatment of Clearmind Medicine Inc.
07 juin 2022 08h30 HE
|
SciSparc Ltd
TEL AVIV, Israel, June 07, 2022 (GLOBE NEWSWIRE) -- SciSparc Ltd. (NASDAQ: SPRC), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the...
SciSparc Ltd. and Clearmind Medicine Inc. Collaboration Yields Another Patent Application for their Proprietary Psychedelic Combination to Treat Cocaine Addiction
02 juin 2022 08h30 HE
|
SciSparc Ltd
No dedicated treatment currently available for cocaine addiction TEL AVIV, Israel, June 02, 2022 (GLOBE NEWSWIRE) -- SciSparc Ltd. (NASDAQ: SPRC), a specialty clinical-stage pharmaceutical...
Purple Biotech Presents Phase 1 Interim Monotherapy Data for NT219 at ASCO 2022, Demonstrating Encouraging Safety & Efficacy Profile
27 mai 2022 07h15 HE
|
Purple Biotech Ltd.
A Confirmed Partial Response in GEJ Patient, Stable Disease demonstrated in 75% of patients with mutated-KRAS colon cancer REHOVOT, Israel, May 27, 2022 (GLOBE NEWSWIRE) --...
SciSparc Announces Ethics Committee Approval to Conduct a Phase IIb Trial in Tourette Syndrome
26 mai 2022 08h30 HE
|
SciSparc Ltd
Ethics Committee approval received from the two sites that will conduct the SCI-110 trial in Germany and Israel TEL AVIV, Israel, May 26, 2022 (GLOBE NEWSWIRE) -- SciSparc Ltd. (NASDAQ: SPRC)...
Claritas Announces Approval from Australian Ethics Committee to Begin Phase 1 Trial of R-107
05 avr. 2022 07h15 HE
|
Claritas Pharmaceuticals, Inc.
SAN FRANCISCO, CA and TORONTO, ON, April 05, 2022 (GLOBE NEWSWIRE) -- Claritas Pharmaceuticals, Inc. (TSX VENTURE EXCHANGE: CLAS and OTC: CLAZF) (the "Company" or "Claritas") today announced that...
Truveta announces new COVID-19 insights and unveils Truveta platform for the first time at #ViVE2022
08 mars 2022 12h04 HE
|
Truveta
Bellevue, WASH, March 08, 2022 (GLOBE NEWSWIRE) -- Truveta, the health system-led company with a vision of saving lives with data, unveiled the Truveta platform in its first public demonstration at...
Ananda Professional is Opening Enrollment to Participate in an IRB-Approved Phase IV Clinical Trial Investigating How CBD May Benefit Women's Health and Wellness
07 mars 2022 13h00 HE
|
Ananda Professional
GEORGETOWN, Ky., March 07, 2022 (GLOBE NEWSWIRE) -- Ananda Professional has committed $40 million to advance the clinical evidence of hemp extract through clinical research. As part of this...
Faro Health Inc. Expands Leadership Team and Announces Participation at SCOPE, Following Its $15 Million Series A Funding
03 févr. 2022 05h00 HE
|
Faro Health Inc
LA JOLLA, Calif., Feb. 03, 2022 (GLOBE NEWSWIRE) -- Faro Health, the clinical protocol solutions company, today announced that it has strengthened its leadership team with the appointment of...